Proteomics International Laboratories Limited

ASX:PIQ.AX

0.7 (AUD) • At close November 8, 2024
Bedrijfsnaam Proteomics International Laboratories Limited
Symbool PIQ.AX
Munteenheid AUD
Prijs 0.7
Beurswaarde 91,702,099
Dividendpercentage 0%
52-weken bereik 0.55 - 1.4
Industrie Biotechnology
Sector Healthcare
CEO Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London)
Website https://www.proteomics.com.au

An error occurred while fetching data.

Over Proteomics International Laboratories Limited

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Proteomics International Laboratories Ltd

Vergelijkbare Aandelen

Vita Life Sciences Limited logo

Vita Life Sciences Limited

VLS.AX

2.1 AUD

SDI Limited logo

SDI Limited

SDI.AX

1.015 AUD

Little Green Pharma Ltd logo

Little Green Pharma Ltd

LGP.AX

0.115 AUD

Kazia Therapeutics Limited logo

Kazia Therapeutics Limited

KZA.AX

0.08 AUD

Prescient Therapeutics Limited logo

Prescient Therapeutics Limited

PTX.AX

0.041 AUD

Universal Biosensors, Inc. logo

Universal Biosensors, Inc.

UBI.AX

0.13 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)